Advertisement
News
Advertisement

Spring Bank Pharma wins $3.9M NIH grant to fight Hep B

Thu, 05/05/2011 - 10:37am
Mass High Tech: The Journal of New England Technology

Milford company Spring Bank Pharmaceuticals Inc. has landed a $3.9 million grant from the National Institutes of Health to further develop a drug candidate to treat Hepatitis B infections.

The five-year grant came from the NIH division, the National Institute of Allergy and Infectious Diseases, and becomes the fourth federal grant the company has taken in based on its platform technology, for a total of more than $12 million, officials said in a release.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading